374Water Stockholders Approve 92.5% Cut in Authorized Shares
374Water Inc.
Subscribe to track SCWO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
374Water Stockholders Approve 92.5% Cut in Authorized Shares
Company: 374Water Inc. (SCWO)
Form: 8-K | Filed: 2026/09/30
Significance: Medium
Event Summary: • Charter Amendment: Authorized Common Stock reduced from 1,000,000,000 to 75,000,000 shares • Shareholder Vote: Re-elected 6 directors, adopted DGCL 102(b)(7) officer exculpation, and ratified Cherry Bekaert LLP as auditor • Record Date Shares Outstanding: 17,493,924 common shares
Key Insight: A dramatic reduction in authorized common shares (92.5% decrease) substantially limits theoretical potential dilution overhang for a $50M micro-cap company.
Market Context: With 17.5M shares outstanding, the 75M authorized limit still gives management adequate headroom (~4.3x current float) for future financing while eliminating excessive authorized share overhang.
Comprehensive Analysis
SEC Filing Analysis: 374Water Inc. (SCWO)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: Stockholders approved a certificate of amendment slashing authorized common shares by 92.5% from 1.0 billion to 75.0 million.
- Market Impact: Neutral to slightly positive due to the significant elimination of potential dilution overhang.
Company Information
| Field | Value |
|---|---|
| Company | 374Water Inc. |
| Ticker Symbol | SCWO |
| CIK | 0000933972 |
| Exchange | The Nasdaq Capital Market |
| Market Cap Tier | Micro-Cap (~$50M) |
Insider Information
| Field | Value |
|---|---|
| Name | None (Corporate Governance Event) |
| CIK | N/A |
| Title/Position | N/A |
| Relationship | N/A |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 8-K |
| Event Date | 2026-09-25 |
| Filing Date | 2026-09-30 |
| Items Reported | Item 5.03, Item 5.07, Item 9.01 |
| Security Type | Common Stock, par value $0.0001 |
Financial Impact Assessment
Capital Structure & Share Count Context
| Metric | Value |
|---|---|
| Market Capitalization | ~$50,000,000 |
| Shares Outstanding (Record Date) | 17,493,924 |
| Previous Authorized Common Stock | 1,000,000,000 |
| New Authorized Common Stock | 75,000,000 |
| Reduction in Authorized Shares | 925,000,000 (-92.5%) |
| Remaining Unissued Capacity | 57,506,076 shares |
Impact Evaluation
- Dilution Overhang Relief: Reducing authorized common shares from 1,000,000,000 to 75,000,000 removes the theoretical overhang of severe future equity issuances, which is a frequent concern for investors in micro-cap companies.
- Capital Flexibility: With ~17.5M shares currently outstanding, 75M authorized shares still provides management with ~4.3x current outstanding shares in flexibility for future capital raises, incentives, and corporate transactions.
- Governance Updates: Stockholders also approved an amendment adopting Delaware DGCL 102(b)(7) officer exculpation protections and re-elected six board members.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-cash corporate governance and charter restructuring event without direct immediate operational cash flow impact, though clearing excessive authorized share overhang is viewed constructively by institutional investors.
Volume & Sentiment
- Expected Volume Impact: Minimal to low immediate trading volume impact.
- Sentiment Indicator: Neutral
Additional Context
- Quorum Adjournment: The Annual Meeting initially convened on September 18, 2026, without a quorum and was adjourned to September 25, 2026, where a quorum was successfully established.
- Proposal Results: All four proposals passed with high approval ratios, including over 9.07M votes cast in favor of reducing authorized shares versus only 71,377 against.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
